Lisheng Xu

Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study

Lisheng Xu, Qi Qian, Yan Zhang et al. · Lung Cancer · 2019 · 37 citations · Full text

Cancer Management, Pathology, First-line Treatment +18

Regulatory mechanism of pyrrolidine dithiocarbamate is mediated by nuclear factor-κB and inhibits neutrophil accumulation in ARDS mice

Hongman Wang, Lisheng Xu, Jiping Zhao et al. · Experimental and Therapeutic Medicine · 2014 · 21 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +25

The effect of apatinib combined with chemotherapy or targeted therapy on non‐small cell lung cancer in vitro and vivo

Mingtao Liu, Xiuxiu Wang, Hui Li et al. · Thoracic Cancer · 2019 · 16 citations · Full text

Mechanical loading promotes Lewis lung cancer cell growth through periostin

Dedong Ma, Hongxiu Lu, Lisheng Xu et al. · In Vitro Cellular & Developmental Biology - Animal · 2009 · 15 citations

Engineering, Cytoskeleton, Cellular Physiology +16

Expression of aldehyde dehydrogenase 1 and ATP-binding cassette superfamily G member 2 is enhanced in primary foci and metastatic lymph node from patients with triple-negative breast cancer

Lisheng Xu, Zhihong Zhao, Kun Wang et al. · Biomedical Research-tokyo · 2017 · 14 citations

Breast Oncology, G Member 2, Pathology +19